RAM
VERA icon

Readystate Asset Management’s Vera Therapeutics VERA Stock Holding History

Readystate Asset Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-401,427
Closed -$9.46M – 702
2025
Q2 		$9.46M Buy
+401,427
New +$9.03M 0.29% 74
2025
Q1 		– Sell
-189,088
Closed -$8M – 756
2024
Q4 		$8M Buy
189,088
+141,405
+297% +$6.26M 0.25% 92
2024
Q3 		$2.11M Sell
47,683
-724,992
-94% -$27.5M 0.04% 358
2024
Q2 		$28M Buy
772,675
+178,584
+30% +$7.08M 0.91% 20
2024
Q1 		$25.6M Buy
+594,091
New +$21.2M 0.36% 31

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Readystate Asset Management's VERA Position: Q3 2025 in Review

Readystate Asset Management sold out of Vera Therapeutics (VERA) in Q3 2025, closing a stake of 401,427 shares — an estimated $9.46M sold.

Readystate Asset Management first reported a position in VERA in Q1 2024 and held it in 5 quarters. The position peaked at $28M in Q2 2024. 175 funds tracked by Wall St. Rank hold VERA as of Q3 2025.

  • Readystate Asset Management reported no remaining Vera Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Readystate Asset Management sold 401,427 Vera Therapeutics shares in Q3 2025, an estimated $9.46M.
  • Readystate Asset Management first reported a position in Vera Therapeutics in Q1 2024 and held it in 5 quarters.
  • Readystate Asset Management's Vera Therapeutics position peaked at $28M in Q2 2024.
  • 175 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2025.

Based on Readystate Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.